Cargando…

Risks and burdens of incident dyslipidaemia in long COVID: a cohort study

BACKGROUND: Non-clinical evidence and a few human studies with short follow-ups suggest increased risk of dyslipidaemia in the post-acute phase of COVID-19 (ie, >30 days after SARS-CoV-2 infection). However, detailed large-scale controlled studies with longer follow-ups and in-depth assessment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Evan, Xie, Yan, Al-Aly, Ziyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Lancet, Diabetes & Endocrinology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873268/
https://www.ncbi.nlm.nih.gov/pubmed/36623520
http://dx.doi.org/10.1016/S2213-8587(22)00355-2